JFG
BIO icon

Jefferies Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jefferies Financial Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,900
Closed -$799K – 1635
2022
Q4 		$799K Buy
+1,900
New +$767K 0.01% 927

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jefferies Financial Group's BIO Position: Q1 2026 in Review

Jefferies Financial Group sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 1,445 shares — an estimated $438K sold.

Jefferies Financial Group first reported a position in BIO in Q4 2022 and held it in 10 quarters. The position peaked at $6.95M in Q4 2022. 392 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Jefferies Financial Group reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 1,445 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $438K.
  • Jefferies Financial Group first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and held it in 10 quarters.
  • Jefferies Financial Group's Bio-Rad Laboratories Class A position peaked at $6.95M in Q4 2022.
  • 392 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.